INTERNEURON PHARMACEUTICALS INCORPORATED – Trademark Portfolio

Entity Type: 03

INTERNEURON PHARMACEUTICALS INCORPORATED holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. The owner is based in Lexington, MA.

One Ledgemont Center

99 Hayden Avenue, Suite 340

Lexington, MA 02173

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IPI
IPI
Abandoned 2000
IPI
IPI
Abandoned 1996
IPI
IPI
Abandoned 1996
IPI
IPI
Abandoned 1992
IPI
IPI
Cancelled 1992
IPI
IPI
Abandoned 1992
IPI
IPI
Cancelled 1992

Trademark Classifications

INTERNEURON PHARMACEUTICALS INCORPORATED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does INTERNEURON PHARMACEUTICALS INCORPORATED have?

INTERNEURON PHARMACEUTICALS INCORPORATED has 7 U.S. trademarks filed with the USPTO.

What trademark classes does INTERNEURON PHARMACEUTICALS INCORPORATED file in?

INTERNEURON PHARMACEUTICALS INCORPORATED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is INTERNEURON PHARMACEUTICALS INCORPORATED's trademark registration success rate?

INTERNEURON PHARMACEUTICALS INCORPORATED has a 0% trademark registration rate, with 0 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.